Authors
Latest:
Tips for optimizing productivity and collaboration for trainees who go unmatched in urology"Going into the upcoming application cycle, I am now a bit more excited and a little less terrified," writes Leah Ashton, MD.
Latest:
Leveraging technology to empower patients and reduce physician burnoutImplementing the right practice technology can not only mitigate physician burnout, it can also enable patients to take charge of their own care experience.
Latest:
Expert shares best practices for keeping a medical office cleanHere are 5 best practices for cleaning a medical office.
Latest:
How recombinant BCG could ease strain of supply issues"I'm all for this great effort by ImmunityBio to provide us with an alternative option,” says Suzanne B. Merrill, MD, FACS.
Latest:
PARP inhibitors: Treating mCRPC from a genetic basisTreatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.
Latest:
Artificial intelligence is the new ghost author in urological research“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.
Latest:
Pain management disparities in kidney stones point to need for guidelines, experts say"For other health care professionals aiming to advocate for equitable changes within their system, it's really important to just start conversations about what you're noticing," says Hailey Frye.
Latest:
Chad Ritenour, MD, on efforts to promote physician well-being at Emory Urology“One of the ways we make the most difference for our patients is we take care of the people who are taking care of them,” says Chad Ritenour, MD.
Latest:
Future Landscape of Prostate Cancer and Rectal SpacersThe expert panel concludes their discussion with a look toward the future of prostate cancer treatment and the evolving role of rectal spacers.
Latest:
Workplace violence in health care remains rampant as preventive efforts continueEven before the pandemic, violence against health care workers was escalating.
Latest:
Bridget Koontz, MD, on PSMA-PET’s impact on treatment planning“For us, being able to know where the cancer is allows us to target it, and I think that lets us be much more effective with our treatment,” says Bridget F. Koontz, MD, FASTRO.
Latest:
Is video-based research feasible for pediatric urology visits?"This first paper was really to show that our research methodology was feasible and acceptable with pediatric urology patients and families. We've done that, and now we have a huge corpus of data that we can further analyze through empirical studies," says Francesca A. Williamson, PhD.
Latest:
FDA approves niraparib/abiraterone tablet for BRCA-positive mCRPCThe approval of the niraparib/abiraterone dual-action tablet for BRCA-positive mCRPC is based on findings from the phase 3 MAGNITUDE study.
Latest:
Closing Thoughts on Urology Practice Management and Treatment of Advanced Prostate CancerClosing out their discussion on how treatment and management of advanced prostate cancer affects their clinical practice, expert urologists consider how the therapeutic landscape continues to evolve and look toward future evolutions in care.
Latest:
Better evidence for efficacy of postmenopausal incontinence treatments neededUrinary symptoms were not significantly improved from local estrogen use in most studies, though an improvement in vaginal symptoms was observed.
Latest:
Study shows proof of concept for sustained release with TAR-200“It's the sustained release and constant exposure to the gemcitabine that's most likely responsible for the high efficacy rates of that we're seeing with the TAR-200 system,” says Siamak Daneshmand, MD.
Latest:
Fluoroscopic Imaging and Other Developments in UrologyThe rationale for utilizing fluoroscopic imaging as well as other evolving technologies that are currently being developed and explored in urology.
Latest:
Urologic research and COVID-19: Unmasking the silver liningIn this column, the authors discuss how the coronavirus disease 2019 (COVID-19) shutdown yielded unexpected opportunities in urologic research.
Latest:
Emmanuel Chartier-Kastler, MD, shares initial data on UroActive System in women with SUI“Now, at 1 year, the 1-hour pad test has been done again, as it's part of the protocol, and she suffered 4 g of incontinence on this test, opposed to 125 g at the beginning,” says Emmanuel Chartier-Kastler, MD, PhD.
Latest:
What factors affect patient reviews of urologists?"What we found is that it's very difficult to raise your review on these websites, but fairly easy to drop your review," says Jake Miller, MD.
Latest:
Treatment and Co-Management of mCRPC Patients with Aggressive DiseaseThis video segment explores treatment approaches for PSMA-positive mCRPC patients, algorithms for monitoring liver dysfunction in advanced CRPC, and exciting advancements in mCRPC treatment.
Latest:
Forward Looking NMIBC Treatment Advancements and Needs in 2024In this final episode, panelists conclude with reflections on the significant progress made in treating NMIBC over the past decade, particularly in the last 5 years. Looking ahead to 2024, experts in urology express excitement about investigational treatments (ie, cretostimogene grenadenorepvec and UGN 102), the potential for personalized medicine, emphasizing the need to understand molecular characteristics of the disease for better treatment customization. The session also highlights the importance of balancing quality of life with effective treatment strategies, and the prospect of utilizing emerging therapies early in the disease process.
Latest:
ARV-766 shows promising efficacy and tolerability in mCRPCResults presented from a phase 1/2 trial of ARV-766 demonstrated efficacy and tolerability in patients whose metastatic castration-resistant prostate cancer progressed after androgen receptor pathway inhibitor therapy.
Latest:
Money Matters: Expert on why annuities are the “Swiss Army knife” of personal financeSocial Security benefits aren’t sufficient to fund retirement for most people. And given the aging of the population and projected trust-fund shortfall, they may be less generous in the future.
Latest:
Geoffrey Sklar, MD, on integrating AI in a way that augments urologic care“I think this is the future, and if we don't go down that path and we don't explore, we're not going to make it better for us and for the patients,” says Geoffrey N. Sklar, MD, FACS.
Latest:
Perioperative cabozantinib shows promise in metastatic kidney cancerPerioperative treatment with cabozantinib is feasible with early signs of clinical activity in patients with intermediate- and poor-risk metastatic renal cell carcinoma.
Latest:
Fertility preservation in patients with testicular cancer"Full discussion of the various fertility preservation options and an understanding of the fertility implications of the various treatment modalities must be understood by patients for them to make optimal decisions for their reproductive futures," write the authors.
Latest:
Race-based adjustment of eGFR: Current opinions and impact on urologic oncology“As other factors such as access to care, socioeconomic conditions, patient preference, and other unknown confounders might have played a role in the observed disparity, it is still unclear whether overestimating the postoperative eGFR of Black patients contributes to the lower use of nephron-sparing approaches in this population,” the authors write.
